Articles & Issues
- Language
- korean
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received July 8, 2019
Accepted September 26, 2019
- This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.
All issues
세포투과 펩티드를 이용한 주름개선 펩티드 GHKs의 피부흡수 증진
Enhancement of Skin Permeation of Anti-wrinkle Peptide GHKs Using Cell Penetrating Peptides
을지대학교 대학원 시니어헬스케어학과 화장품약리학 전공, 13135 경기도 성남시 수정구 산성대로 553
Department of Senior Healthcare, majored in Cosmetic Pharmacology, Eulji University, 553, Sanseong-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13135, Korea
msshin@eulji.ac.kr
Korean Chemical Engineering Research, February 2020, 58(1), 29-35(7), 10.9713/kcer.2020.58.1.29 Epub 4 February 2020
Download PDF
Abstract
본 연구에서는 경피흡수가 잘 안되는 주름개선 펩티드인 GHK, GHK-Cu, Pal-GHK에 대하여 세포투과 펩티드인 알르기닌 올리고머(tetra-D-arginine, R4)와 hexa-D-arginine, R6)를 첨가한 후 경피 투과도를 측정하여 그 결과를 다음 6 가지 경우로 분석하였다. 첫번째로 주름개선 펩티드만 함유한 경우는 구리이온(Cu2+)과 팔미트산이 경피 투과율을 증진시키는 것을 알 수 있다. 두번째로, GHK에 알르기닌 올리고머(R4, R6)를 첨가한 경우는 알르기닌 올리고머(R4, R6)가 경피 투과율을 증가시켰으며, R4에서 더 좋은 경피 투과율 증가를 나타났다. 세번째로, GHK-Cu에 R4, R6를 첨가한 경우는 경피 투과율 증가가 나타났으며, R6 < R4 경피 투과율 순서로 나타났다. 네번째로 Pal-GHK에 R4, R6를 첨가한 경우에도 경피 투과율 증가가 나타났으며, R6 < R4 경피 투과율 순서로 나타났다. 다섯번 째로, R4를 GHK, GHK-Cu, Pal-GHK에 첨가한 경우에는 GHK+R4 < GHK-Cu+R4 < Pal-GHK+R4 순서로 경피 투과율 증가가 나타났다. 마지막으로 R6를 GHK, GHK-Cu, Pal-GHK에 첨가한 경우에는 GHK+R4 < GHK-Cu+R4 < Pal-GHK+R4 순서로 경피 투과율 증가가 나타났다. 이를 통하여 주름 개선 펩티드인 GHK, GHK-Cu, Pal-GHK의 피부 투과를 증가를 위한 최적의 조건을 제시하여 그 효능을 극대화할 수 있는 방안을 제시함으로써 주름 개선 기능성 화장품에서의 폭넓은 활용과 응용을 제안하고자 한다.
In this study, the skin permeability was measured by adding cell penetrating peptides, arginine oligomers; (tetra-D-arginine (R4) and hexa-D-arginine (R6)) to little skin-permeable anti-wrinkle peptides (GHK, GHK-Cu, and Pal-GHK), and the results were analyzed by the following six cases. First, in cases where only anti-wrinkle peptides were contained, copper ions (Cu2+) and palmitic acid enhanced the transdermal permeability. Second, when arginine oligomers (R4, R6) were added to GHK, arginine oligomers (R4, R6) increased percutaneous permeability, and R4 showed better percutaneous permeability. Third, the addition of R4 and R6 to GHK-Cu resulted in increased percutaneous transmittance, followed by R6 < R4 percutaneous transmittance. Fourth, when R4 and R6 were added to Pal-GHK, the percutaneous permeability increased with results in R6 < R4 order. Fifth, when R4 was added to GHK, GHK-Cu, and Pal-GHK, the transdermal permeability increased in the order of GHK+R4 < GHK-Cu+R4 < Pal-GHK+R4. Finally, the addition of R6 to GHK, GHK-Cu and Pal- GHK also resulted in increased percutaneous transmittance in the order of GHK+R4 < GHK-Cu+R4 < Pal-GHK+R4. This study provides optimal conditions for enhancing skin absorption of anti-wrinkle peptides GHK, GHK-Cu, and Pal- GHK, and propose a wide range of applications in anti-wrinkle functional cosmetics by suggesting ways to maximize their efficacy.
References
Jung DY, Magazine IEEE, 44(12), 16 (2017)
Oh JS, J. Cult. Exchange, 6(3), 77 (2017)
Kang KS, Kim ID, Kwon RH, Heo YY, Oh SH, Kim MA, Jung HJ, Kang HY, Ha BJ, J. Life Sci., 17, 1147 (2007)
Moh SH, Jung DH, Kim HS, Cho MJ, Seo HH, Kim SJ, Kor. Soc. Biotech. Bioeng, 26(6), 483 (2011)
Yoo BJ, Yeon JJ, BT News, 24(2), 52 (2017)
Li H, Low YSJ, Chong HP, Zin MT, Lee CY, Li B, Leolukman M, Kang L, Pharmaceu. Res., 32(8), 2678 (2015)
Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP, FEBS Letters, 238(2), 343 (1988)
Pickart L, J. Biomat. Sci. Polym. Ed., 19(8), 969 (2008)
Maquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, Monboisse JC, Chastang F, Birembaut P, Gillery P, J. Clinical Invest., 92(5), 2368 (1993)
Godet D, Marie PJ, Cell. Mol. Biol., 41(8), 1081 (1995)
Pickart L, Freedman JH, Loker WJ, Nature, 288(5792), 715 (1980)
Lee HJ, Huang YW, Chiou SH, Aronstam RS, Sci. Reports, 9(1), 93 (2019)
Vive E, Brodin P, Lebleu B, J. Biol. Chem., 272(25), 16010 (1997)
Wang K, Zhao X, Yang F, Liu P, Xing J, J. Biomed. Nanotech., 15(3), 417 (2019)
Yi DD, Li GM, Li G, Liang W, Biochem. Biophys. Res. Commun., 359(4), 1024 (2007)
Liang W, Davalian D, Torchilin VP, Yao Xue Xue Bao, 39(12), 1011 (2004)
Mazurowska L, Mojski LM, Int. J. Cosmet. Sci., 59(1), 59 (2008)
Kim MH, J. Skin Barrier Res., 11(1), 28 (2009)
Franz TJ, J. Invest. Dermatol., 64(3), 190 (1975)
Kim EN, Park KH, Kim BH, Jeong GS, Kor. J. Pharma., 49(2), 165 (2018)
Kim JH, Yang HJ, Won BR, Ahn YJ, Kang MK, Park SN, J. Soc. Cosmet. Sci. Kor, 35(2), 91 (2009)
Jin LH, Bahn JH, Eum SW, Kwon HY, Jang SH, et al., Biol. Med., 31, 1509 (2001)
Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender PA, Khavari PA, Nat. Med., 6(11), 1253 (2000)
Oh JS, J. Cult. Exchange, 6(3), 77 (2017)
Kang KS, Kim ID, Kwon RH, Heo YY, Oh SH, Kim MA, Jung HJ, Kang HY, Ha BJ, J. Life Sci., 17, 1147 (2007)
Moh SH, Jung DH, Kim HS, Cho MJ, Seo HH, Kim SJ, Kor. Soc. Biotech. Bioeng, 26(6), 483 (2011)
Yoo BJ, Yeon JJ, BT News, 24(2), 52 (2017)
Li H, Low YSJ, Chong HP, Zin MT, Lee CY, Li B, Leolukman M, Kang L, Pharmaceu. Res., 32(8), 2678 (2015)
Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP, FEBS Letters, 238(2), 343 (1988)
Pickart L, J. Biomat. Sci. Polym. Ed., 19(8), 969 (2008)
Maquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, Monboisse JC, Chastang F, Birembaut P, Gillery P, J. Clinical Invest., 92(5), 2368 (1993)
Godet D, Marie PJ, Cell. Mol. Biol., 41(8), 1081 (1995)
Pickart L, Freedman JH, Loker WJ, Nature, 288(5792), 715 (1980)
Lee HJ, Huang YW, Chiou SH, Aronstam RS, Sci. Reports, 9(1), 93 (2019)
Vive E, Brodin P, Lebleu B, J. Biol. Chem., 272(25), 16010 (1997)
Wang K, Zhao X, Yang F, Liu P, Xing J, J. Biomed. Nanotech., 15(3), 417 (2019)
Yi DD, Li GM, Li G, Liang W, Biochem. Biophys. Res. Commun., 359(4), 1024 (2007)
Liang W, Davalian D, Torchilin VP, Yao Xue Xue Bao, 39(12), 1011 (2004)
Mazurowska L, Mojski LM, Int. J. Cosmet. Sci., 59(1), 59 (2008)
Kim MH, J. Skin Barrier Res., 11(1), 28 (2009)
Franz TJ, J. Invest. Dermatol., 64(3), 190 (1975)
Kim EN, Park KH, Kim BH, Jeong GS, Kor. J. Pharma., 49(2), 165 (2018)
Kim JH, Yang HJ, Won BR, Ahn YJ, Kang MK, Park SN, J. Soc. Cosmet. Sci. Kor, 35(2), 91 (2009)
Jin LH, Bahn JH, Eum SW, Kwon HY, Jang SH, et al., Biol. Med., 31, 1509 (2001)
Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender PA, Khavari PA, Nat. Med., 6(11), 1253 (2000)